Subscribe To
Ocgn stock alert: why is ocugen heating up today?
Shares of OCGN stock are flying higher after the FDA lifted its clinical hold on Covaxin, the company's coronavirus drug ...
February 22, 2022, 10:55 am
Ocgn stock alert: why is ocugen heating up today?
Shares of OCGN stock are flying higher after the FDA lifted its clinical hold on Covaxin, the company's coronavirus drug ...
February 22, 2022, 10:55 am
Ocgn stock alert: why is ocugen heating up today?
Shares of OCGN stock are flying higher after the FDA lifted its clinical hold on Covaxin, the company's coronavirus drug ...
February 22, 2022, 10:55 am
Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate
Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...
February 22, 2022, 10:30 am
Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate
Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...
February 22, 2022, 10:30 am
Moderna's stock gains 3% as it moves forward with phase 3 clinical trial for rsv vaccine candidate
Shares of Moderna Inc. MRNA, +2.82% gained 3.0% in trading on Monday after the company said it began a Phase 3 clinical trial evaluating its respirato...
February 22, 2022, 10:30 am
4d pharma receives us regulatory green light for phase i trial of its parkinson's disease candidates
4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) has received the green light for a first-in-human trial of its Parkinson's disease ...
February 22, 2022, 2:56 am
4d pharma receives us regulatory green light for phase i trial of its parkinson's disease candidates
4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) has received the green light for a first-in-human trial of its Parkinson's disease ...
February 22, 2022, 2:56 am
4d pharma receives us regulatory green light for phase i trial of its parkinson's disease candidates
4D pharma PLC (AIM:DDDD, NASDAQ:LBPS) has received the green light for a first-in-human trial of its Parkinson's disease ...
February 22, 2022, 2:56 am
Despite an 80% drop, ocugen stock is still too pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it's best to...
February 21, 2022, 4:46 pm
Despite an 80% drop, ocugen stock is still too pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it's best to...
February 21, 2022, 4:46 pm
Despite an 80% drop, ocugen stock is still too pricey
Until the hype surrounding its Covid-19 vaccine candidate is no longer priced into shares, it's best to...
February 21, 2022, 4:46 pm
Moderna to develop three new mrna vaccine candidates
Shares of Moderna Inc. MRNA, -3.59% gained 0.1% on Friday after the company said it is now developing mRNA vaccines for herpes simplex virus, varicell...
February 18, 2022, 8:44 am
Moderna to develop three new mrna vaccine candidates
Shares of Moderna Inc. MRNA, -3.59% gained 0.1% on Friday after the company said it is now developing mRNA vaccines for herpes simplex virus, varicell...
February 18, 2022, 8:44 am
Moderna to develop three new mrna vaccine candidates
Shares of Moderna Inc. MRNA, -3.59% gained 0.1% on Friday after the company said it is now developing mRNA vaccines for herpes simplex virus, varicell...
February 18, 2022, 8:44 am
Mirati (mrtx) down on longer review period for adagrasib nda
The FDA accepts Mirati's (MRTX) NDA for its lung cancer candidate, adagrasib. A decision is expected by...
February 17, 2022, 1:05 pm
Mirati (mrtx) down on longer review period for adagrasib nda
The FDA accepts Mirati's (MRTX) NDA for its lung cancer candidate, adagrasib. A decision is expected by...
February 17, 2022, 1:05 pm
Mirati (mrtx) down on longer review period for adagrasib nda
The FDA accepts Mirati's (MRTX) NDA for its lung cancer candidate, adagrasib. A decision is expected by...
February 17, 2022, 1:05 pm
Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy trial of its COVID-19 ...
February 17, 2022, 11:40 am
Regencell bioscience's covid-19 candidate shows encouraging action on mild to moderate symptoms
Regencell Bioscience Holdings Limited (NASDAQ: RGC) announced the results from the EARTH efficacy trial of its COVID-19 ...
February 17, 2022, 11:40 am